SCHEMBL15699715

SCHEMBL15699715

CC(C)[C@H](NC(=O)CCOCCOCCOCCOCCOCCOCCNC(=O)CBr)C(=O)N[C@@H](CCCN)C(=O)Nc1ccc(CO)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FURIN P09958 6/20 0.39
▸ KLKB1 P03952 1/20 0.37
▸ CALCRL Q16602 1/20 0.36
▸ CHRNA1 P02708 1/20 0.36
▸ CHRNG P07510 1/20 0.36
▸ CHRNB1 P11230 1/20 0.36
▸ CHRND Q07001 1/20 0.36
▸ NPY1R P25929 2/20 0.36
▸ NPY4R P50391 2/20 0.36
▸ OPRK1 P41145 2/20 0.34
▸ CTSL P07711 1/20 0.34
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA4 P22748 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ CA14 Q9ULX7 2/20 0.34
▸ TLR2 O60603 1/20 0.34
▸ NMT2 O60551 1/20 0.34
▸ NMT1 P30419 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18392587 0.94 FURIN (0.38) FURINKLKB1CALCRLCHRNA1CHRNG
SCHEMBL19359701 0.93 FURIN (0.39) FURINNPY1RNPY4R
SCHEMBL14138390 0.87 OPRK1 (0.40) FURINKLKB1CHRNA1CHRNGCHRNB1
SCHEMBL22138596 0.86 FURIN (0.39) FURINKLKB1CHRNA1CHRNGCHRNB1
SCHEMBL27447192 0.86 FURIN (0.39) FURINKLKB1CHRNA1CHRNGCHRNB1
SCHEMBL20705515 0.86 FURIN (0.39) FURINKLKB1CHRNA1CHRNGCHRNB1
SCHEMBL25787504 0.83 FURIN (0.40) FURINKLKB1CHRNA1CHRNGCHRNB1
SCHEMBL15699736 0.83 FURIN (0.40) FURINKLKB1CHRNA1CHRNGCHRNB1
SCHEMBL16645085 0.83 FURIN (0.45) FURINKLKB1CALCRLCTSLNMT2
SCHEMBL21234897 0.83 FURIN (0.48) FURINKLKB1CALCRLCHRNA1CHRNG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9504669-B2 Spliceostatin analogs and methods for their preparation PFIZER INC. (US) 2016-11-29 — — US disclosed
US-20160022626-A1 SPLICEOSTATIN ANALOGS AND METHODS FOR THEIR PREPARATION PFIZER (US) 2016-01-28 — — US disclosed
US-9169264-B2 Spliceostatin analogs and methods for their preparation PFIZER INC. (US) 2015-10-27 — — US disclosed
US-20140134193-A1 SPLICEOSTATIN ANALOGS AND METHODS FOR THEIR PREPARATION PFIZER INC. (US) 2014-05-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022626-A1 SPLICEOSTATIN ANALOGS AND METHODS FOR THEIR PREPARATION SF3B5, SNRPA1, SF3B1 FURIN 766/4885KLKB1 736/4885CALCRL 3976/4885
US-20140134193-A1 SPLICEOSTATIN ANALOGS AND METHODS FOR THEIR PREPARATION SF3B5, SNRPA1, SF3B1 FURIN 766/4885KLKB1 736/4885CALCRL 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback